First-in-Human, Single-Ascending Dose and Food Effect Studies to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Cetagliptin, a Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
2014 ◽
Vol 103
(3)
◽
pp. 395-401
◽
2019 ◽
Vol 32
(7)
◽
pp. 695-702
◽
2019 ◽
Vol Volume 11
◽
pp. 7427-7438
◽
2013 ◽
Vol 8
(1)
◽
pp. 21-35
◽
2011 ◽
Vol 2
(4)
◽
pp. 230
◽
2013 ◽
Vol 46
(5)
◽
pp. 334-341
2010 ◽
Vol 67
(18)
◽
pp. 1515-1525
◽